HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

Dementia prevention through our life course

Natalie Mackenzie discusses the importance of proactive measures for brain health, emphasising the critical foundations of cognitive health and the changes leading to dementia,...

Addressing a hidden crisis: The global neglect of bone health

Professor Nicholas Harvey, President of the International Osteoporosis Foundation, posits the urgent need to address the burden of bone health and the associated chronic conditions, which are putting immense strain on public health and health services.

Higher blood sugar spikes linked to increased Alzheimer’s risk, Liverpool study finds

A University of Liverpool study finds people with higher post‑meal blood sugar have a significantly greater risk of developing Alzheimer’s disease.

New European initiative aims to speed up Alzheimer’s diagnosis and treatment

A new European initiative, in partnership with King’s College London, aims to accelerate earlier diagnosis and improve access to treatment for people living with Alzheimer’s disease.

World-first UCL project shows promise for treating low eye pressure

UCL-led researchers launch a world-first project targeting low eye pressure, offering new hope for patients at risk of vision loss and glaucoma-related damage.

Nearly 90% of Alzheimer’s cases linked to a single gene

Large-scale UK Biobank research suggests that variations in the APOE gene, linked to up to 90% of Alzheimer’s cases.

BHF renews £10m investment in pioneering cardiovascular data science centre

The British Heart Foundation has renewed £10m in funding for the Data Science Centre to advance cardiovascular research.

New study aims for drug-free remission in arthritis patients

UK & Italian researchers launch ARCADIA consortium with £3m funding to define true remission and help children and adults with inflammatory arthritis live drug‑free.

UCL researchers use AI to identify two forms of MS for the first time              

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis, supporting the potential for more personalised care and improved treatment decisions for patients worldwide.

New breakthrough could bring osteoporosis treatments to patients faster

University of Sheffield researchers helped secure FDA approval for a new bone imaging method that could speed up osteoporosis drug trials, meaning new treatments may reach patients faster than ever.

41% of adults in England show signs of tooth decay, survey reveals

New research from UCL reveals alarming levels of tooth decay in adults in England, highlighting the need for improved dental care and public health initiatives.

AI brain scan model spots strokes, tumours and aneurysms

Researchers at King’s College London have developed an AI model that can detect strokes, brain tumours, and aneurysms from MRI scans, helping doctors make faster, more accurate diagnoses.

New Respiratory Therapy Solutions framework helps patients stay well at home this winter

As winter illnesses surge across the UK, a new national initiative aims to help people with long-term respiratory conditions stay healthier and avoid unnecessary hospital visits.

Weight-loss drug liraglutide may slow Alzheimer’s decline, new study suggests

New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% within a year.

Only 1 in 10 gets the right care for COPD

A shock survey by charity Asthma + Lung UK reveals that more than 90% of people with COPD are receiving inadequate care, with those living in more deprived communities five times more likely to die from the condition.

UK confirms first case of dangerous clade‑1b mpox strain

The UK Health Security Agency (UKHSA) has confirmed the first UK case of the more serious Mpox virus “clade Ib” strain.

Common pesticides and chemicals damage “good” gut bacteria

A significant study from the University of Cambridge finds that everyday pesticides and industrial chemicals can kill beneficial gut bacteria, potentially harming digestion, immunity, and overall health.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders